AstraZeneca (Canada) View Homepage


Ontology type: grid:Company  | foaf:Organization     


Organization Info

Publications in SciGraph latest 20 shown

  • 2017-12 Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012–2015 in ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY
  • 2010-11 The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2010 A Children’s Asthma Education Program: Roaring Adventures of Puff (RAP), Improves Quality of Life in CANADIAN RESPIRATORY JOURNAL
  • 2010 A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care in CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • 2010 Barriers to the Implementation of Practice Guidelines in Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Qualitative Approach in CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • 2007-05 The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD) in PHARMACOECONOMICS
  • 2006-12 The cumate gene-switch: a system for regulated expression in mammalian cells in BMC BIOTECHNOLOGY
  • 2006-09 Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2005-12 The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2005-12 The impact of illness in patients with moderate to severe gastro-esophageal reflux disease in BMC GASTROENTEROLOGY
  • 2005-01 A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2000-01 Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 1999-10 A multicentre trial of ropivacaine 7.5 mg·ml−1vs bupivacaine 5 mg·ml−1 for supra clavicular brachial plexus anesthesia in JOURNAL CANADIEN D'ANESTHÉSIE
  • 1999-08 Addition of femoral 3-in-1 blockade to intra-articular ropivacaine 0.2% does not reduce analgesic requirements following arthroscopic knee surgery in JOURNAL CANADIEN D'ANESTHÉSIE
  • 1998-05 Abstracts in JOURNAL CANADIEN D'ANESTHÉSIE
  • 1997-08 EMLA® patch for intravenous cannulation in adult surgical outpatients in JOURNAL CANADIEN D'ANESTHÉSIE
  • JSON-LD is the canonical representation for SciGraph data.

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "foaf:homepage": [
          {
            "id": "http://www.astrazeneca.ca/en/Home/"
          }
        ], 
        "grid:crossrefFunderId": [
          {
            "@value": "100008207"
          }
        ], 
        "grid:establishedYear": [
          {
            "@value": "1999-01-01", 
            "type": "http://www.w3.org/2001/XMLSchema#gYear"
          }
        ], 
        "grid:hasAddress": [
          {
            "id": "http://www.grid.ac/institutes/grid.424144.3/address-0"
          }
        ], 
        "grid:hasParent": [
          {
            "id": "http://www.grid.ac/institutes/grid.417815.e"
          }
        ], 
        "grid:id": [
          {
            "@value": "grid.424144.3"
          }
        ], 
        "grid:isni": [
          {
            "@value": "0000 0004 0434 7116"
          }
        ], 
        "grid:wikipediaPage": [
          {
            "id": "https://en.wikipedia.org/wiki/AstraZeneca"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.424144.3", 
        "rdfs:label": "AstraZeneca (Canada)", 
        "sdDataset": "grid", 
        "skos:prefLabel": [
          {
            "@value": "AstraZeneca (Canada)"
          }
        ], 
        "type": [
          "http://xmlns.com/foaf/0.1/Organization", 
          "http://www.grid.ac/ontology/Company"
        ]
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://www.grid.ac/institutes/grid.424144.3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://www.grid.ac/institutes/grid.424144.3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://www.grid.ac/institutes/grid.424144.3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://www.grid.ac/institutes/grid.424144.3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    13 TRIPLES      12 PREDICATES      13 URIs      6 LITERALS

    Subject Predicate Object
    1 grid-institutes:grid.424144.3 sgo:sdDataset grid
    2 grid:crossrefFunderId 100008207
    3 grid:establishedYear 1999-01-01
    4 grid:hasAddress grid-institutes:grid.424144.3/address-0
    5 grid:hasParent grid-institutes:grid.417815.e
    6 grid:id grid.424144.3
    7 grid:isni 0000 0004 0434 7116
    8 grid:wikipediaPage https://en.wikipedia.org/wiki/AstraZeneca
    9 rdf:type grid:Company
    10 foaf:Organization
    11 rdfs:label AstraZeneca (Canada)
    12 skos:prefLabel AstraZeneca (Canada)
    13 foaf:homepage http://www.astrazeneca.ca/en/Home/
     




    Preview window. Press ESC to close (or click here)


    ...